Home›People›Mark Bakken
MB

Mark Bakken

Director at Cancer IQ.

Director
Updated Oct 29, 2026·Latest SEC filing May 26, 2026·Suggest an edit

About Mark Bakken

Mark Bakken is a director at Cancer IQ.

Mark Bakken first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Mark Bakken in the role, so the role may have started earlier or lasted longer.

Cancer IQ Inc.
Director
2020 – 2026 · Chicago, IL
CancerIQ provides software that helps clinicians identify patients eligible for cancer screening and testing.

Key Colleagues at Startups

The people Mark Bakken works with at each company, as listed on that company's latest Form D.

Cancer IQ Inc. · Form D/A, May 26, 2026
HL
Haibo Lu
Executive officer and director
JK
Olufeyikemi Ayodele
Olufeyikemi Ayodele
CEO & Co-Founder, director

Sources

  1. SECCancer IQ Inc. Form D/A, filed May 26, 2026